youtube_live
Q3 2026 earnings • released • EPS beat +16.67% • Revenue miss -0.37%
See resultschevron_right
OSUR:NASDAQ
OraSure Technologies Inc
$3.44
arrow_downward
-3.37%(-0.12) 1D
Nov 12, 10:53:42 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OSUR...
Open
$3.52
High
$3.52
Low
$3.40
Mkt. cap
237.52M
Avg. vol.
610.60K
Volume
40.17K
52-wk high
$4.58
52-wk low
$2.08
EPS
-$0.69
Beta
1.08
Shares outstanding
69.05M
No. of employees
500
Open
$3.52
High
$3.52
Low
$3.40
Mkt. cap
237.52M
Avg. vol.
610.60K
Volume
40.17K
52-wk high
$4.58
52-wk low
$2.08
EPS
-$0.69
Beta
1.08
Shares outstanding
69.05M
No. of employees
500
News stories
From web sources and news partners
Quantisnow
·
1 hour ago
OraSure Technologies (OSUR): Diagnostics sales rose 16% to $16.8 million in Q3 2026
GuruFocus
·
2 days ago
OraSure Technologies (OSUR) Reports Q3 Revenue Growth and FDA EU
TradingView
·
2 days ago
OraSure Technologies Q3 Earnings Call Highlights
Investing.com
·
2 days ago
OraSure earnings beat by $0.09, revenue fell short of estimates
Profile
OraSure Technologies, Inc. is a Bethlehem, Pennsylvania–based company in the medical device industry. Their products include diagnostic testing kits. The company had recently developed OraQuick testing kit, the first over-the-counter home HIV test. Wikipedia
About OraSure Technologies Inc
CEOCarrie Eglinton Manner
Employees500
FoundedDec 11, 1987
HeadquartersBethlehem, Pennsylvania, United States
SectorHealth Care
IndustryMedical device
Websiteorasure.com